UPDATED Apr 22, 2024
Defensive mid-caps and large-caps in descending order of expected ROE in three years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
GLO | UK£2.51 | 0.2% | 28.9% | UK£1.7b | UK£1.91 | PE11x | E-38.3% | 4.9% | ||
IMB | UK£18.19 | 5.1% | -6.7% | UK£15.6b | UK£22.78 | PE6.7x | E0.01% | 8.1% | ||
BVIC | UK£8.61 | 2.7% | -6.1% | UK£2.1b | UK£9.75 | PE17.2x | E10.5% | 3.6% | ||
DGE | UK£28.57 | 3.1% | -23.7% | UK£63.5b | UK£30.88 | PE18.4x | E4.9% | 2.7% | ||
ULVR | UK£38.85 | 3.1% | -11.5% | UK£97.2b | UK£42.32 | PE17.4x | E4.3% | 3.8% | ||
GSK | UK£16.40 | -0.2% | 11.2% | UK£67.0b | UK£20.06 | PE13.6x | E9.4% | 3.5% | ||
AZN | UK£112.50 | 2.1% | -7.5% | UK£174.4b | UK£130.74 | PE36.2x | E16.4% | 2.0% | ||
RKT | UK£42.66 | 2.0% | -34.1% | UK£30.1b | UK£56.73 | PE18.4x | E11.6% | 4.5% | ||
CCH | UK£25.18 | 4.5% | 4.0% | UK£9.2b | UK£27.50 | PE16.8x | E10.3% | 3.2% | ||
HIK | UK£18.18 | 0.6% | -1.4% | UK£4.0b | UK£23.01 | PE26.2x | E18.1% | 3.2% | ||
TSCO | UK£2.91 | 1.7% | 4.7% | UK£20.3b | UK£3.30 | PE11.5x | E2.8% | 4.2% | ||
SN. | UK£9.75 | 1.7% | -23.5% | UK£8.5b | UK£13.26 | PE39.9x | E21.2% | 3.1% | ||
BATS | UK£23.60 | 3.2% | -19.2% | UK£52.5b | UK£31.45 | PS1.9x | E51.1% | 10.0% | ||
TATE | UK£6.47 | 4.0% | -20.6% | UK£2.6b | UK£8.58 | PE14.9x | E9.1% | 3.0% | ||
SSE | UK£16.65 | 0.9% | -9.5% | UK£18.1b | UK£20.63 | PE31.3x | E13.1% | 3.6% | ||
CNA | UK£1.32 | 1.0% | 15.7% | UK£7.0b | UK£1.73 | PE1.8x | E-41.4% | 3.0% | ||
PNN | UK£6.65 | 2.8% | -23.0% | UK£1.9b | UK£8.11 | PS2.3x | E35.1% | 6.6% | ||
NG. | UK£10.46 | 2.0% | -8.2% | UK£38.9b | UK£11.87 | PE15.2x | E6.4% | 5.4% | ||
DRX | UK£4.90 | -2.9% | -20.9% | UK£1.9b | UK£7.57 | PE3.4x | E-15.9% | 4.7% | ||
SBRY | UK£2.69 | 3.3% | -4.1% | UK£6.3b | UK£3.02 | PE81.7x | E25.0% | 6.3% |